RE:Financials are outThere is no revenue reported for the period Feb 1 - Apr 30, 2021. From this we can conclude that there were no Covid 19 LFA V1 sales. The market did not react to this because the failed V1 commercialization and failed V2 clinical tests are already baked into the current share price. The good news is that they have $2M in cash raised from PP in December, warrants, ATM financing and government grant. There is no immediate solvency risk. The MD&A doesn't give any new information. It's all been covered in the monthly CSE Form 7 filings. Overall, no surprises and no new information. I expect share price to remain within the current trading range in the 0.30s. IMO management will do a pivot. In their investment presentation (on their website), they said they will commercialize the bovine TB test and concussion test. They also talk about commercializing consumer health testing LFAs. I am personally looking to see whether they bring forward these activities forward much faster. This will determine whether I purchase more or whether I sell my initial position which I just purchassed. Again, I am looking forward to good discussion. I will pi$$ on anyone who pi$$es on me. I have already put on ignore MikeyH, Dart, Moemoney, Kaiser and a few others who pollute this board.with utter garbage commentary. MikeyH even offers ill will to you and he hopes you lose all your money. Kaiser is a total bore and can't get off asking how Dart's and Moemoney's $1000+ projection is going. Give it up. Kaiser, Dart, MikeyH and Moemoney - go spead your wisdom somewhere else, like a QAon forum. They will like you there..